US Stock MarketDetailed Quotes

Candel Therapeutics (CADL)

Watchlist
  • 6.300
  • 0.0000.00%
Close Jan 22 16:00 ET
  • 6.300
  • 0.0000.00%
Post 20:01 ET
345.86MMarket Cap-11.25P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Candel Therapeutics (CADL) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-55.73%-10.24M
-43.45%-8.89M
-2.11%-8.62M
21.09%-27.02M
21.67%-5.81M
25.37%-6.57M
13.86%-6.2M
22.01%-8.44M
-8.99%-34.24M
-7.80%-7.42M
Net income from continuing operations
-5.85%-11.27M
78.43%-4.8M
189.76%7.38M
-45.44%-55.18M
-26.84%-14.07M
-26.21%-10.65M
-131.30%-22.24M
6.53%-8.22M
-101.87%-37.94M
-118.28%-11.1M
Operating gains losses
-149.94%-818K
-142.58%-5.68M
-212,485.71%-14.88M
2,445.21%20.8M
1,102.47%5.83M
383.39%1.64M
9,363.19%13.34M
98.92%-7K
94.58%-887K
117.67%485K
Depreciation and amortization
-20.41%195K
-2.81%242K
-2.39%245K
3.13%990K
-1.61%245K
0.00%245K
5.51%249K
9.13%251K
23.39%960K
12.67%249K
Other non cash items
-16.05%136K
-14.79%144K
-14.61%152K
-0.45%663K
-12.00%154K
-4.71%162K
3.68%169K
12.66%178K
13.07%666K
10.76%175K
Change In working capital
-57.82%356K
-84.81%67K
-8.50%-1.83M
165.90%346K
-53.48%743K
179.77%844K
-69.18%441K
32.59%-1.68M
-839.44%-525K
2,349.30%1.6M
-Change in prepaid assets
124.80%61K
-1,464.79%-1.94M
528.21%167K
-53.48%234K
-48.57%377K
62.10%-246K
-87.64%142K
94.66%-39K
20.91%503K
73,400.00%733K
-Change in payables and accrued expense
-61.78%464K
427.48%2.13M
-21.32%-1.86M
323.44%572K
-56.35%488K
506.02%1.21M
-28.62%404K
6.52%-1.53M
-592.31%-256K
1,125.69%1.12M
-Change in other current assets
-766.67%-40K
-38.10%13K
-64.29%5K
145.69%53K
-47.83%12K
-70.00%6K
113.21%21K
--14K
---116K
--23K
-Change in other current liabilities
0.77%-129K
-10.32%-139K
-10.57%-136K
-10.56%-513K
-10.74%-134K
-10.17%-130K
-11.50%-126K
-9.82%-123K
0.00%-464K
0.82%-121K
-Change in other working capital
----
----
----
----
----
----
----
----
-386.57%-192K
-196.89%-156K
Cash from discontinued investing activities
Operating cash flow
-55.73%-10.24M
-43.45%-8.89M
-2.11%-8.62M
21.09%-27.02M
21.67%-5.81M
25.37%-6.57M
13.86%-6.2M
22.01%-8.44M
-8.99%-34.24M
-7.80%-7.42M
Investing cash flow
Cash flow from continuing investing activities
-117K
-416.67%-31K
57.14%-3K
94.29%-16K
88.89%-3K
0
96.45%-6K
-136.84%-7K
78.41%-280K
90.22%-27K
Net PPE purchase and sale
---117K
-416.67%-31K
57.14%-3K
94.29%-16K
88.89%-3K
--0
96.45%-6K
-136.84%-7K
78.41%-280K
90.22%-27K
Cash from discontinued investing activities
Investing cash flow
---117K
-416.67%-31K
57.14%-3K
94.29%-16K
88.89%-3K
--0
96.45%-6K
-136.84%-7K
78.41%-280K
90.22%-27K
Financing cash flow
Cash flow from continuing financing activities
-301.01%-3.37M
796.86%17.44M
-49.00%-1.87M
78,017.36%94.28M
76,061.16%91.91M
1.68M
1.95M
-1.26M
-100.61%-121K
-436.11%-121K
Net issuance payments of debt
0.00%-2.5M
0.00%-2.5M
-49.97%-2.5M
---9.17M
---2.5M
---2.5M
---2.5M
---1.67M
--0
--0
Net common stock issuance
-117.50%-713K
470.13%19.7M
106.45%384K
--101.76M
--94.04M
--4.07M
--3.46M
--186K
--0
--0
Proceeds from stock option exercised by employees
-80.58%20K
-75.15%246K
8.85%246K
--1.69M
--370K
--103K
--990K
--226K
--0
--0
Net other financing activities
----
----
----
----
----
----
----
----
---121K
----
Cash from discontinued financing activities
Financing cash flow
-301.01%-3.37M
796.86%17.44M
-49.00%-1.87M
78,017.36%94.28M
76,061.16%91.91M
--1.68M
--1.95M
---1.26M
-100.61%-121K
-436.11%-121K
Net cash flow
Beginning cash position
364.79%100.95M
255.79%92.43M
188.46%102.92M
-49.26%35.68M
-61.10%16.82M
-58.36%21.72M
-56.36%25.98M
-49.26%35.68M
-15.34%70.32M
-44.16%43.25M
Current changes in cash
-180.31%-13.72M
300.09%8.52M
-8.13%-10.49M
294.09%67.24M
1,237.33%86.1M
45.06%-4.9M
42.16%-4.26M
10.19%-9.7M
-171.90%-34.65M
-6.25%-7.57M
End cash Position
418.48%87.23M
364.79%100.95M
255.79%92.43M
188.46%102.92M
188.46%102.92M
-61.10%16.82M
-58.36%21.72M
-56.36%25.98M
-49.26%35.68M
-49.26%35.68M
Free cash flow
-57.92%-10.38M
-43.81%-8.92M
-2.06%-8.62M
22.08%-27.04M
22.12%-5.82M
26.24%-6.57M
15.75%-6.2M
22.93%-8.45M
-6.07%-34.7M
-4.30%-7.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -55.73%-10.24M-43.45%-8.89M-2.11%-8.62M21.09%-27.02M21.67%-5.81M25.37%-6.57M13.86%-6.2M22.01%-8.44M-8.99%-34.24M-7.80%-7.42M
Net income from continuing operations -5.85%-11.27M78.43%-4.8M189.76%7.38M-45.44%-55.18M-26.84%-14.07M-26.21%-10.65M-131.30%-22.24M6.53%-8.22M-101.87%-37.94M-118.28%-11.1M
Operating gains losses -149.94%-818K-142.58%-5.68M-212,485.71%-14.88M2,445.21%20.8M1,102.47%5.83M383.39%1.64M9,363.19%13.34M98.92%-7K94.58%-887K117.67%485K
Depreciation and amortization -20.41%195K-2.81%242K-2.39%245K3.13%990K-1.61%245K0.00%245K5.51%249K9.13%251K23.39%960K12.67%249K
Other non cash items -16.05%136K-14.79%144K-14.61%152K-0.45%663K-12.00%154K-4.71%162K3.68%169K12.66%178K13.07%666K10.76%175K
Change In working capital -57.82%356K-84.81%67K-8.50%-1.83M165.90%346K-53.48%743K179.77%844K-69.18%441K32.59%-1.68M-839.44%-525K2,349.30%1.6M
-Change in prepaid assets 124.80%61K-1,464.79%-1.94M528.21%167K-53.48%234K-48.57%377K62.10%-246K-87.64%142K94.66%-39K20.91%503K73,400.00%733K
-Change in payables and accrued expense -61.78%464K427.48%2.13M-21.32%-1.86M323.44%572K-56.35%488K506.02%1.21M-28.62%404K6.52%-1.53M-592.31%-256K1,125.69%1.12M
-Change in other current assets -766.67%-40K-38.10%13K-64.29%5K145.69%53K-47.83%12K-70.00%6K113.21%21K--14K---116K--23K
-Change in other current liabilities 0.77%-129K-10.32%-139K-10.57%-136K-10.56%-513K-10.74%-134K-10.17%-130K-11.50%-126K-9.82%-123K0.00%-464K0.82%-121K
-Change in other working capital ---------------------------------386.57%-192K-196.89%-156K
Cash from discontinued investing activities
Operating cash flow -55.73%-10.24M-43.45%-8.89M-2.11%-8.62M21.09%-27.02M21.67%-5.81M25.37%-6.57M13.86%-6.2M22.01%-8.44M-8.99%-34.24M-7.80%-7.42M
Investing cash flow
Cash flow from continuing investing activities -117K-416.67%-31K57.14%-3K94.29%-16K88.89%-3K096.45%-6K-136.84%-7K78.41%-280K90.22%-27K
Net PPE purchase and sale ---117K-416.67%-31K57.14%-3K94.29%-16K88.89%-3K--096.45%-6K-136.84%-7K78.41%-280K90.22%-27K
Cash from discontinued investing activities
Investing cash flow ---117K-416.67%-31K57.14%-3K94.29%-16K88.89%-3K--096.45%-6K-136.84%-7K78.41%-280K90.22%-27K
Financing cash flow
Cash flow from continuing financing activities -301.01%-3.37M796.86%17.44M-49.00%-1.87M78,017.36%94.28M76,061.16%91.91M1.68M1.95M-1.26M-100.61%-121K-436.11%-121K
Net issuance payments of debt 0.00%-2.5M0.00%-2.5M-49.97%-2.5M---9.17M---2.5M---2.5M---2.5M---1.67M--0--0
Net common stock issuance -117.50%-713K470.13%19.7M106.45%384K--101.76M--94.04M--4.07M--3.46M--186K--0--0
Proceeds from stock option exercised by employees -80.58%20K-75.15%246K8.85%246K--1.69M--370K--103K--990K--226K--0--0
Net other financing activities -----------------------------------121K----
Cash from discontinued financing activities
Financing cash flow -301.01%-3.37M796.86%17.44M-49.00%-1.87M78,017.36%94.28M76,061.16%91.91M--1.68M--1.95M---1.26M-100.61%-121K-436.11%-121K
Net cash flow
Beginning cash position 364.79%100.95M255.79%92.43M188.46%102.92M-49.26%35.68M-61.10%16.82M-58.36%21.72M-56.36%25.98M-49.26%35.68M-15.34%70.32M-44.16%43.25M
Current changes in cash -180.31%-13.72M300.09%8.52M-8.13%-10.49M294.09%67.24M1,237.33%86.1M45.06%-4.9M42.16%-4.26M10.19%-9.7M-171.90%-34.65M-6.25%-7.57M
End cash Position 418.48%87.23M364.79%100.95M255.79%92.43M188.46%102.92M188.46%102.92M-61.10%16.82M-58.36%21.72M-56.36%25.98M-49.26%35.68M-49.26%35.68M
Free cash flow -57.92%-10.38M-43.81%-8.92M-2.06%-8.62M22.08%-27.04M22.12%-5.82M26.24%-6.57M15.75%-6.2M22.93%-8.45M-6.07%-34.7M-4.30%-7.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -